KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Tax Provisions (2018 - 2025)

Historic Tax Provisions for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$62.4 million.

  • BioNTech SE's Tax Provisions fell 4427.49% to -$62.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year increase of 11107.14%. This contributed to the annual value of $13.3 million for FY2024, which is 10481.44% up from last year.
  • As of Q3 2025, BioNTech SE's Tax Provisions stood at -$62.4 million, which was down 4427.49% from $18.2 million recorded in Q2 2025.
  • BioNTech SE's Tax Provisions' 5-year high stood at $3.8 billion during Q3 2021, with a 5-year trough of -$1.8 billion in Q4 2021.
  • In the last 5 years, BioNTech SE's Tax Provisions had a median value of -$18.1 million in 2024 and averaged -$84.4 million.
  • Per our database at Business Quant, BioNTech SE's Tax Provisions crashed by 92063100345.86% in 2021 and then surged by 94616.76% in 2025.
  • Over the past 5 years, BioNTech SE's Tax Provisions (Quarter) stood at -$1.8 billion in 2021, then soared by 151.51% to $912.0 million in 2022, then tumbled by 124.22% to -$220.9 million in 2023, then skyrocketed by 120.17% to $44.6 million in 2024, then plummeted by 240.1% to -$62.4 million in 2025.
  • Its Tax Provisions stands at -$62.4 million for Q3 2025, versus $18.2 million for Q2 2025 and $31.1 million for Q1 2025.